e-Article
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
Document Type
Article
Author
Elmariah, H.; Nishihori, T.; Faramand, R.; Mishra, A.; Khimani, F.; Fernandez, H.; Lazaryan, A.; Nieder, M.; Perez, L.; Liu, H.; Pidala, J.; Anasetti, C.; Locke, F.; Bejanyan, N.; Otoukesh, S.; Ali, H.; Arslan, S.; Nakamura, R.; Marcucci, G.; Forman, S.J.; Al Malki, M.M.; Kumar, A.; Shouse, G.; Pourhassan, H.
Source
In: Transplantation and Cellular Therapy . (Transplantation and Cellular Therapy, February 2024, 30(2):229.e1-229.e11)
Subject
Language
English
ISSN
26666367